Pms-Methotrexate Injection 22.5 mg

PMS-Methotrexate Injection 22.5 mg is a subcutaneous solution used for various medical conditions. This medication, containing methotrexate sodium, is manufactured by Pharmascience Inc. in Canada.

PMS-Methotrexate Injection 22.5 mg is primarily used for its antimetabolite properties. It is often prescribed for conditions that require suppression of cell growth, such as certain types of cancer and autoimmune diseases. The injection form allows for targeted delivery, which may be beneficial for specific treatment protocols.

Common effects of PMS-Methotrexate Injection 22.5 mg may include localized reactions at the injection site, such as redness or swelling. Systemic effects can vary and may include fatigue, nausea, or changes in appetite. Individual responses to the medication can differ, and it is important to monitor for any unusual symptoms.

PMS-Methotrexate Injection 22.5 mg should be handled with care, as it is a potent medication. It is essential to follow the prescribed administration guidelines and to store the solution properly to maintain its efficacy. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

PMS-Methotrexate Injection 22.5 mg may interact with other medications, including certain antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and immunosuppressants. Alcohol and other substances that affect liver function should be avoided, as they can exacerbate the effects of methotrexate. Always consult a healthcare provider before combining medications.